Fol. Biol. 2003, 49, 51-62
https://doi.org/10.14712/fb2003049020051
The 3' Untranslated Region of the Chicken c-src Protooncogene Modulates Gene Expression
References
1. 2000) An alternative, human SRC promoter and its regulation by hepatic nuclear factor-1alpha. J. Biol. Chem. 275, 37604-37611.
< , K., Ritchie, S. A., Dehm, S. M., Snyder, K., Boyd, F. M. (https://doi.org/10.1074/jbc.M004882200>
2. 1996) Influence of the transduced 3'UTR of the c-src oncogene on tumor growth induced by the v-src gene of the PR2257 virus. J. Gen. Virol. 77, 1189-1192.
< , J., Plachý, J. (https://doi.org/10.1099/0022-1317-77-6-1189>
3. 1996) Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling. J. Biol. Chem. 271, 16798-16806.
< , M. A., Hunter, T. (https://doi.org/10.1074/jbc.271.28.16798>
4. 1986) Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83, 1670-1674.
< , D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., Cerami, A. (https://doi.org/10.1073/pnas.83.6.1670>
5. 1985) Chickens selected for the absence of ev loci contain in their genome sequences distantly related to Rous sarcoma virus. Molek. Gen. 3, 6-10.
, M. V., Tikhonenko, A. T., Zaitsevskaya, T. E., Denisova, R. A., Obukh, I. B., Gudkov, A. V. (
6. 2000) Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat. Biotechnol. 18, 509-514.
< , H. J., Takabayashi, K., Chen, P. M., Nguyen, M. D., Corr, M., Tuck, S., Raz, E. (https://doi.org/10.1038/75365>
7. 1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156-159.
< , P., Sacchi, N. (https://doi.org/10.1016/0003-2697(87)90021-2>
8. 2001) SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Lett. 487, 367-371.
< , S., Senger, M. A., Bonham, K. (https://doi.org/10.1016/S0014-5793(00)02354-1>
9. 2002) Proteasome inhibitors reduce luciferase and beta-galactosidase activity in tissue culture cells. J. Biol. Chem. 277, 20120-20123.
< , B. J., Archer, T. K. (https://doi.org/10.1074/jbc.C200173200>
10. 1996) The Src SH3 domain is required for DNA synthesis induced by platelet-derived growth factor and epidermal growth factor. J. Biol. Chem. 271, 16807-16812.
< , T., Alonso, G., Roche, S., Courtneidge, S. A. (https://doi.org/10.1074/jbc.271.28.16807>
11. 1998) Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17, 3448-3460.
< , X. C., Steitz, J. A. (https://doi.org/10.1093/emboj/17.12.3448>
12. 1994) Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc. Natl. Acad. Sci. USA 91, 11207-11211.
< , F. B., Carson C. C., Levine, T., Keene, J. D. (https://doi.org/10.1073/pnas.91.23.11207>
13. 1989) Transduction of the cellular src gene and 3' adjacent sequences in avian sarcoma virus PR2257. J. Virol. 63, 481-492.
< , J., Dezélée, P., Barnier, J. V., Svoboda, J., Nehyba, J., Karakoz, I., Rynditch, A. V., Yatsula, B. A., Calothy, G. (https://doi.org/10.1128/jvi.63.2.481-492.1989>
14. 2001) Regulatory functions of 3'UTRs. Biochem. Biophys. Res. Commun. 288, 291-295.
< , E. A., Wilsczynska, A., Siedlecki, J. A. (https://doi.org/10.1006/bbrc.2001.5738>
15. 1999) Ubiquitin-dependent degradation of active Src. Curr. Biol. 9, 1039-1042.
< , Y., Martin, G. S. (https://doi.org/10.1016/S0960-9822(99)80453-9>
16. 1999) Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc. Natl. Acad. Sci. USA 96, 13738-13743.
< , K. F., Shoji, I., Cooper, E. M., Kumar, S., Oda, H., Howley, P. M. (https://doi.org/10.1073/pnas.96.24.13738>
17. 2001) CpG island protects Rous sarcoma virus-derived vectors integrated into nonpermissive cells from DNA methylation and transcriptional suppression. Proc. Natl. Acad. Sci. USA 98, 565-569.
< J., Hájková, P., Plachý, J., Elleder, D., Stepanets, V., Svoboda, J. (https://doi.org/10.1073/pnas.98.2.565>
18. 1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21, 187-190.
< , R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., Yeatman, T. J. (https://doi.org/10.1038/5971>
19. 2000) Role of Src expression and activation in human cancer. Oncogene 19, 5636-5642.
< , R. B., Yeatman, T. J. (https://doi.org/10.1038/sj.onc.1203912>
20. 1999) Possible involvement of proteasomes (prosomes) in AUUUA-mediated mRNA decay. J. Biol. Chem. 274, 5925-5930.
< , A. S., Petit, F., Kreutzer-Schmid, C., Gaedigk, R., Schmid, H. P. (https://doi.org/10.1074/jbc.274.9.5925>
21. 1997) Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the α-globin mRNA stability complex. Mol. Cell. Biol. 17, 4870-4876.
< , M., DeMaria, C. T., Brewer, G., Novick, K. (https://doi.org/10.1128/MCB.17.8.4870>
22. 1999) Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284, 499-502.
< G., Cuesta R., Brewer G., Schneider R. J. (https://doi.org/10.1126/science.284.5413.499>
23. 2002) Ubiquitindependent mechanism regulates rapid turnover of AU-rich cytokine mRNAs. Proc. Natl. Acad. Sci. USA 99, 1842-1846.
< , G., Sarkar, B., Schneider, R. J. (https://doi.org/10.1073/pnas.042575699>
24. 1993) Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13, 3494-3504.
, T. D., Gao, F., King, P. H., Andrews, L. G., Keene, J. D. (
25. 1999) Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13, 1884-1897.
< , P., Chen, C. Y.A., Shyu, A. B. (https://doi.org/10.1101/gad.13.14.1884>
26. 1986) Characterization of a MH2 mutant lacking the v-myc oncogene. Virology 153, 272-279.
< P., Henry C., Denhez F., Amouyel P., Bechade C., Calothy G., Debuire B., Stehelin D., Saule S. (https://doi.org/10.1016/0042-6822(86)90030-9>
27. 1998) RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17, 3461-3470.
< , S. S. Y., Chen, C. Y. A., Xu, N., Shyu, A. B. (https://doi.org/10.1093/emboj/17.12.3461>
28. 1988) Structure and expression of lck transcripts in human lymphoid cells. J. Cell. Biochem. 38, 117-126.
< , R. M., Marth, J. D., Lewis, D. B., Peet, R., Ziegler, S. F., Wilson, C. B. (https://doi.org/10.1002/jcb.240380206>
29. 2001) Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276, 73-81.
< , G., Mignone, F., Gissi, C., Grillo, G., Licciulli, F., Liuni, S. (https://doi.org/10.1016/S0378-1119(01)00674-6>
30. 1974) Transformation of chick embryo neuroretinal cells by Rous sarcoma virus in vitro: induction of cell proliferation. Science 185, 709-710.
< B., Calothy G. (https://doi.org/10.1126/science.185.4152.709>
31. 1989) Prague inbred lines of chickens: a biological model for MHC research. Folia Biol. (Praha) 35, 177-196.
, J., Vilhelmová, M., Karakoz, I., Schulmannová, J. (
32. 1994) Src-specific immunity in inbred chickens bearing v-src and RSV-induced tumors. Immunogenet. 40, 257-265.
< , J., Hála, K., Hejnar, J., Geryk, J., Svoboda, J. (https://doi.org/10.1007/BF00189970>
33. 2000) Transcription of the human c-Src promoter is dependent on Sp1, a novel pyrimidine binding factor Spy, and can be inhibited by triplex-forming oligonucleotides. J. Biol. Chem. 275, 847-854.
< , S., Boyd, F.M., Wong, J., Bonham, K. (https://doi.org/10.1074/jbc.275.2.847>
34. 1995) Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division. Science 269, 1567-1569.
< , S., Fumagalli, S., Courtneidge, S. A. (https://doi.org/10.1126/science.7545311>
35. 1986) A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
< , G., Kamen, R. (https://doi.org/10.1016/0092-8674(86)90341-7>
36. 1992) Tumor induction by LTR, v-src, LTR DNA in four B (MHC) congenic lines of chickens. Immunogenet. 35, 309-315.
< , J., Plachý, J., Hejnar, J., Karakoz, I., Guntaka, R. V., Geryk, J. (https://doi.org/10.1007/BF00189893>
37. 1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72, 955-962.
, T., Yamamoto, H., Shimada, S., Abe, H., Fukuda, T., Fujisawa, Y., Furutani, Y., Yano, O., Kataoka, T., Sudo, T. (
38. 1997) Regulation of p56lck messenger turnover upon T cell activation: involvement of the 3' untranslated region in stability as determined in cell-free extracts. Biochem. Biophys. Res. Commun. 233, 419-424.
< , C., Vaquero, C. (https://doi.org/10.1006/bbrc.1997.6477>
39. 1994a) The 3' region of c-src gene mRNA is entirely included in exon 12 and does not encode another protein. Biochem. Biophys. Acta 1218, 473-477.
, B. A., Michailik, A. A., Rynditch, A. V., Calothy, G., Dezélée, P. (
40. 1994b) Origin and evolution of the c-src-transducing avian sarcoma virus PR2257. J. Gen. Virol. 75, 2777-2781.
< , B. A., Geryk, J., Briešťanská, J., Karakoz, I., Svoboda, J., Rynditch, A. V., Calothy, G., Dezélée, P. (https://doi.org/10.1099/0022-1317-75-10-2777>
41. 1996) Phenotypic changes induced by wild type and variant c-src genes carrying C-terminal sequence alterations. Oncogene 13, 2717-2725.
, B. A., Plachý, J., Mikhailik, A., David-Pfeuty, T., Lecoq, O., Yatsula, V., Geryk, J., Svoboda, J., Calothy, G., Dezélée, P. (